These newer therapies, including copyright , belong to a class of drugs called GLP-1 agents. Primarily intended for treating high blood sugar, they function by encouraging the pancreas to produce sufficient insulin and curbing excessive glucose levels. Furthermore , their potential to support slimming has led to significant interest and broad use ,